Intravenous L-arginine in Oligohydramnios
Annals of International Medical and Dental Research · 2026-06 · 12 (3) · 63-70
DOI: 10.53339/aimdr.2026.12.3.9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of International Medical and Dental Research, 2026-06. Verfasst von Natasha Tiluttoma Aleem und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Oligohydramnios is associated with increased maternal and fetal morbidity and mortality. Intravenous amino acid supplementation has emerged as a potential therapy to improve amniotic fluid levels and pregnancy outcomes. Previous studies suggest that L-arginine and branched-chain amino acids may enhance fetal growth and reduce preterm birth. This study aims to evaluate the effectiveness of an intravenous amino acid solution rich in L-arginine in pregnant women with oligohydramnios.
Methods
The prospective study was conducted in the Department of Obstetrics and Gynaecology at Asgar Ali Hospital, Dhaka, over two years, extending from March 2022 to January 2024, among 48 pregnant women with oligohydramnios. The participant received five (5) doses of IV amino acid supplementation during gestational weeks 28–34, under the supervision of a physician.
Results
The study’s mean age of pregnant women was 28.19 ± 4.27 years, and the mean gestational age at diagnosis was 30.04 ± 1.89 weeks. Most cases of oligohydramnios with IUGR were identified at 28–30 weeks of gestation, accounting for 69.2% of the study population. Mean fetal weight before administration of the IV amino acid solution was 1424.04 ± 656.20 gm. After 3 weeks of treatment, the mean fetal weight increased to 2313.27 ± 528.16 gm, with an average fetal weight gain of 889.23 ± 716.72 gm, which was statistically significant (P < 0.001). Before administering the IV amino acid solution, the mean amniotic fluid index (AFI) was 5.00 ± 0.75 cm, which improved to 7.69 ± 0.84 cm after 3 weeks.
Conclusions
Intravenous supplementation of amino acids, particularly L-arginine and branched-chain amino acids, may offer potential benefits for pregnant women with oligohydramnios. These supplements could enhance uteroplacental blood flow and improve fetal nutrient delivery, potentially leading to better fetal growth outcomes.
Zitieren
APA
Aleem, N. T., Mirza, N., & Akhter, M. (2026). Intravenous L-arginine in Oligohydramnios. Annals of International Medical and Dental Research, 12(3), 63-70. https://doi.org/10.53339/aimdr.2026.12.3.9
Vancouver
Aleem NT, Mirza N, Akhter M. Intravenous L-arginine in Oligohydramnios. Annals of International Medical and Dental Research. 2026;12(3):63-70. doi:10.53339/aimdr.2026.12.3.9
BibTeX
@article{Aleem2026,
author = {Aleem, Natasha Tiluttoma and Mirza, Nahid and Akhter, Mahabuba},
title = {Intravenous L-arginine in Oligohydramnios},
journal = {Annals of International Medical and Dental Research},
year = {2026},
volume = {12},
number = {3},
pages = {63--70},
doi = {10.53339/aimdr.2026.12.3.9}
}
EUVIMED